Gabriella Gamberi

Summary

Affiliation: Istituti Ortopedici Rizzoli
Country: Italy

Publications

  1. ncbi request reprint Presence and expression of the simian virus-40 genome in human giant cell tumors of bone
    G Gamberi
    Laboratory of Oncologic Research, Rizzoli Institute, Bologna, Italy
    Genes Chromosomes Cancer 28:23-30. 2000
  2. ncbi request reprint Identification of markers of possible prognostic value in 57 giant cell tumors of bone
    Gabriella Gamberi
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, I 40136 Bologna, Italy
    Oncol Rep 10:351-6. 2003
  3. ncbi request reprint Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone
    G Gamberi
    Laboratory of Oncologic Research, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy
    Ann Oncol 15:498-503. 2004
  4. pmc Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years
    Gabriella Gamberi
    Department of Pathology, Section of Molecular Biology, Rizzoli Institute, Via Di Barbiano 1 10, Bologna, Italy
    J Mol Diagn 13:313-24. 2011
  5. ncbi request reprint Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years
    Cristina Ferrari
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Bologna, Italy
    Acta Orthop Scand 75:487-91. 2004
  6. doi request reprint CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases
    Marco Gambarotti
    Department of Pathology, Rizzoli Institute, Bologna, Italy
    Histopathology 69:624-34. 2016
  7. doi request reprint MDM2 and CDK4 expression in periosteal osteosarcoma
    Alberto Righi
    Pathology Department, Rizzoli Institute, Bologna, Italy 40136 Electronic address
    Hum Pathol 46:549-53. 2015
  8. doi request reprint Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases
    Alberto Righi
    Department of Pathology, Rizzoli Institute Department of Biomedical and Neuromotor Sciences, University of Bologna Department of Pathology, Villa Erbosa Hospital, Bologna Section of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence Department of Pathology, Treviso Regional Hospital, Treviso, Italy
    Am J Surg Pathol 39:691-9. 2015
  9. doi request reprint Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma
    Stefania Benini
    Department of Pathology, Rizzoli Institute, Bologna, Italy Electronic address
    J Mol Diagn 16:314-23. 2014
  10. ncbi request reprint Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells
    Maria Serena Benassi
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Bologna, Italy
    Cancer Lett 250:194-205. 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Presence and expression of the simian virus-40 genome in human giant cell tumors of bone
    G Gamberi
    Laboratory of Oncologic Research, Rizzoli Institute, Bologna, Italy
    Genes Chromosomes Cancer 28:23-30. 2000
    ..001). These results show that SV40 DNA sequences and SV40 Tag are present in GCTs and might induce FOS activity. These data suggest that SV40 might play a role in the development and progression of some GCTs...
  2. ncbi request reprint Identification of markers of possible prognostic value in 57 giant cell tumors of bone
    Gabriella Gamberi
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, I 40136 Bologna, Italy
    Oncol Rep 10:351-6. 2003
    ..Therefore, the evaluation of the expression levels of these proteins at the time of diagnosis may be taken into consideration for a classification of GCT into categories characterized by a different risk to relapse...
  3. ncbi request reprint Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone
    G Gamberi
    Laboratory of Oncologic Research, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy
    Ann Oncol 15:498-503. 2004
    ..Few prognostic markers have been reported to predict the clinical outcome of GCT patients, so is very important to find the factor that can be implicated in its potential aggressiveness...
  4. pmc Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years
    Gabriella Gamberi
    Department of Pathology, Section of Molecular Biology, Rizzoli Institute, Via Di Barbiano 1 10, Bologna, Italy
    J Mol Diagn 13:313-24. 2011
    ..Finally, we collected the most prevalent breakpoints reported in the literature, indicating which exons are involved, the sequence breakpoints, and the NCBI reference sequences...
  5. ncbi request reprint Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years
    Cristina Ferrari
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Bologna, Italy
    Acta Orthop Scand 75:487-91. 2004
    ..The activity of matrix metalloproteinases (MMPs) in degrading extracellular matrix is controlled by activation of proenzymes and inhibition of MMP tissue inhibitors (TIMPs)...
  6. doi request reprint CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases
    Marco Gambarotti
    Department of Pathology, Rizzoli Institute, Bologna, Italy
    Histopathology 69:624-34. 2016
    ..Round-cell sarcomas lacking specific translocations represent a diagnostic challenge. The aim of this study was to describe seven cases of CIC-DUX4 fusion-positive sarcomas, including the first reported example arising primarily in bone...
  7. doi request reprint MDM2 and CDK4 expression in periosteal osteosarcoma
    Alberto Righi
    Pathology Department, Rizzoli Institute, Bologna, Italy 40136 Electronic address
    Hum Pathol 46:549-53. 2015
    ..Therefore, when compared with low-grade central and parosteal osteosarcomas, MDM2 and CDK4 markers cannot be used diagnostically to differentiate this subtype of osteosarcoma. ..
  8. doi request reprint Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases
    Alberto Righi
    Department of Pathology, Rizzoli Institute Department of Biomedical and Neuromotor Sciences, University of Bologna Department of Pathology, Villa Erbosa Hospital, Bologna Section of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence Department of Pathology, Treviso Regional Hospital, Treviso, Italy
    Am J Surg Pathol 39:691-9. 2015
    ..The strong IHC expression of SATB2 associated with CD99 immunonegativity and the absence of EWSR1 and FUS gene rearrangements in small cell osteosarcoma argues against the existence of a morphologic/genetic continuum with Ewing sarcoma...
  9. doi request reprint Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma
    Stefania Benini
    Department of Pathology, Rizzoli Institute, Bologna, Italy Electronic address
    J Mol Diagn 16:314-23. 2014
    ....
  10. ncbi request reprint Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells
    Maria Serena Benassi
    Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Bologna, Italy
    Cancer Lett 250:194-205. 2007
    ....
  11. ncbi request reprint Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness
    Laura Pazzaglia
    Department of Muscoloskeletal Oncology, Rizzoli Orthopaedic Institute, 40100, Bologna, Italy
    Anticancer Res 24:967-72. 2004
    ..The S100A4 gene may affect the invasive properties of tumor cells through modulation of metalloproteinases (MMPs) and their inhibitors (TIMPs)...
  12. doi request reprint Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas
    Manuela Salerno
    Department of Orthopaedic Pathophysiology and Regenerative Medicine, Istituto Ortopedico Rizzoli, Bologna, Italy
    Int J Oncol 43:95-102. 2013
    ..This method provides a reliable preclinical model that can be used for future studies aimed at investigating crucial aspects of sarcoma biology, such as resistance to treatments and relapse...
  13. ncbi request reprint Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR
    Julia Asp
    Research Centre for Endocrinology and Metabolism, Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg University, Goteborg, Sweden
    Int J Oncol 27:1577-82. 2005
    ..Both p16 and Id1 showed varied gene expression patterns among the samples and none of these genes could be significantly correlated to prognosis...